206 related articles for article (PubMed ID: 36936374)
41. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer.
Zhou Z; Xie X; Wang X; Zhang X; Li W; Sun T; Cai Y; Wu J; Dang C; Zhang H
Front Genet; 2021; 12():623424. PubMed ID: 33664769
[TBL] [Abstract][Full Text] [Related]
42. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma.
Chen B; Deng T; Deng L; Yu H; He B; Chen K; Zheng C; Wang D; Wang Y; Chen G
BMC Cancer; 2021 Nov; 21(1):1211. PubMed ID: 34772375
[TBL] [Abstract][Full Text] [Related]
43. Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction.
Lao Y; Wang Y; Yang J; Liu T; Ma Y; Luo Y; Sun Y; Li K; Zhao X; Niu X; Xi Y; Zhong C
Front Oncol; 2022; 12():941868. PubMed ID: 36439494
[TBL] [Abstract][Full Text] [Related]
44. Construction of a prognostic model of colon cancer patients based on metabolism-related lncRNAs.
Li C; Liu Q; Song Y; Wang W; Zhang X
Front Oncol; 2022; 12():944476. PubMed ID: 36248984
[TBL] [Abstract][Full Text] [Related]
45. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.
Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM
Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558
[TBL] [Abstract][Full Text] [Related]
46. Identification of tryptophan metabolic gene-related subtypes, development of prognostic models, and characterization of tumor microenvironment infiltration in gliomas.
Liu Y; Xiang J; Liao Y; Peng G; Shen C
Front Mol Neurosci; 2022; 15():1037835. PubMed ID: 36407768
[TBL] [Abstract][Full Text] [Related]
47. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
Front Genet; 2022; 13():938250. PubMed ID: 36561319
[No Abstract] [Full Text] [Related]
48. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
[TBL] [Abstract][Full Text] [Related]
49. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
[TBL] [Abstract][Full Text] [Related]
50. MSC Senescence-Related Genes Are Associated with Myeloma Prognosis and Lipid Metabolism-Mediated Resistance to Proteasome Inhibitors.
Cao YJ; Zheng YH; Li Q; Zheng J; Ma LT; Zhao CJ; Li T
J Oncol; 2022; 2022():4705654. PubMed ID: 36467498
[TBL] [Abstract][Full Text] [Related]
51. A novel signature based on pyroptosis-related genes for predicting prognosis and treatment response in prostate cancer patients.
Xiao X; Li J; Wan S; Wu M; Li Z; Tian J; Mi J
Front Genet; 2022; 13():1006151. PubMed ID: 36386841
[No Abstract] [Full Text] [Related]
52. Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes.
He J; Li W; Li Y; Liu G
Transl Cancer Res; 2020 May; 9(5):3518-3538. PubMed ID: 35117717
[TBL] [Abstract][Full Text] [Related]
53. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
[TBL] [Abstract][Full Text] [Related]
54. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
55. A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
Liu J; Yang J; Gao F; Li S; Nie S; Meng H; Sun R; Wan Y; Jiang Y; Ma X; Cheng W
DNA Cell Biol; 2020 Jul; 39(7):1328-1346. PubMed ID: 32456463
[TBL] [Abstract][Full Text] [Related]
56. SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironment.
Liu Y; Ma G; Liu J; Zheng H; Huang G; Song Q; Pang Z; Du J
Heliyon; 2022 Oct; 8(10):e10866. PubMed ID: 36217463
[TBL] [Abstract][Full Text] [Related]
57. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
[TBL] [Abstract][Full Text] [Related]
58. Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis.
Chen Q; Qiu B; Zeng X; Hu L; Huang D; Chen K; Qiu X
Cancer Cell Int; 2021 Mar; 21(1):182. PubMed ID: 33766042
[TBL] [Abstract][Full Text] [Related]
59. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
60. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]